Prudential Financial’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Prudential Financial’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,896	Closed	-$315K	–	2399
2016 Q1	$315K	Buy	5,896 +1,559	+36%	+$115K	﹤0.01%	2105
2015 Q4	$490K	Sell	4,337 -28,610	-87%	-$3.15M	﹤0.01%	1977
2015 Q3	$3.88M	Buy	32,947 +10,100	+44%	+$1.32M	0.01%	1152
2015 Q2	$1.77M	Sell	22,847 -42,980	-65%	-$2.82M	﹤0.01%	1625
2015 Q1	$3.81M	Buy	+65,827	New	+$2.79M	0.01%	1277
2014 Q3	–	Sell	-33,254	Closed	-$590K	–	2467
2014 Q2	$590K	Buy	+33,254	New	+$535K	﹤0.01%	1974

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Prudential Financial's ANAC Position: Q2 2016 in Review

Prudential Financial sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 5,896 shares — an estimated $315K sold.

Prudential Financial first reported a position in ANAC in Q2 2014 and held it in 6 quarters. The position peaked at $3.88M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Prudential Financial reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Prudential Financial sold 5,896 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $315K.
Prudential Financial first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 6 quarters.
Prudential Financial's ANACOR PHARMACEUTICALS INC COM position peaked at $3.88M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Prudential Financial's 13F filing for Q2 2016, filed 9 Aug 2016.